Caitong International Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Caitong International Asset Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20	Buy	+5	New	+$24	﹤0.01%	2079

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Caitong International Asset Management's TLSI Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 5 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

Caitong International Asset Management held 5 shares of TriSalus Life Sciences worth $20 as of Q1 2026.
TriSalus Life Sciences was a new Caitong International Asset Management position in Q1 2026.
TriSalus Life Sciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2079 holding.
84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.